<DOC>
	<DOCNO>NCT02725086</DOCNO>
	<brief_summary>A Randomized , Open-label , Two-way Crossover , Open-label Clinical Trial Compare Pharmacokinetic/Pharmacodynamic Properties Safety Subcutaneous Administration Leucostim速 Neupogen速 Healthy Adult Volunteers</brief_summary>
	<brief_title>Evaluation Pharmacokinetic/Pharmacodynamic Properties Safety Leucostim速 Compared Neupogen速 Healthy Adult Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Lenograstim</mesh_term>
	<criteria>Age 19 45 year BMI 18.5 25.0 kg/m2 Value ANC ( absolute neutrophil count ) inside normality range screen Subjects history presence clinically relevant hypersensitivity reaction investigational drug ( GCSF ) ingredients/additives Subjects clinically relevant history allergic reaction Subjects history acute infectious disease within 2 week prior administration investigational product At investigator 's discretion , subject consider inappropriate participate study due condition include screening result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>